SCHEMBL6167928

SCHEMBL6167928

NS(=O)(=O)c1ccccc1C(=O)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 8/20 0.57
CA1 P00915 8/20 0.57
CA2 P00918 8/20 0.57
CA5A P35218 5/20 0.51
STS P08842 1/20 0.49
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 5/20 0.45
CA7 P43166 4/20 0.45
CA5B Q9Y2D0 4/20 0.45
CA14 Q9ULX7 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
AKR1B1 P15121 1/20 0.44
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101008 0.83 CA9 (0.53) CA9CA1CA2STSTSHR
SCHEMBL7129795 0.79 MEN1 (0.62) MEN1KMT2ACES2CES1AKR1B1
SCHEMBL28043229 0.79 CA1 (0.61) CA9CA1CA2CA5ACA12
SCHEMBL386092 0.79 CA1 (0.61) CA9CA1CA2CA5ACA12
SCHEMBL31191409 0.77 CA1 (0.63) CA9CA1CA2CA5ATSHR
SCHEMBL353738 0.77 CA1 (0.63) CA9CA1CA2CA5ATSHR
SCHEMBL31598814 0.76 CA1 (0.57) CA9CA1CA2CA5ASTS
SCHEMBL28109387 0.76 CA1 (0.61) CA9CA1CA2CA5ATSHR
Hydrochloric Acid SCHEMBL3878957 0.76 CA1 (0.61) CA9CA1CA2CA5ATSHR
SCHEMBL29586388 0.76 HPGD (0.56) CA9CA1CA2TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed